Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 31, 2019 Off

Isentress – API Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Isentress – API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Isentress – API Insight, 2019…

May 31, 2019 Off

Nexium – API Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Nexium – API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Nexium – API Insight, 2019…

May 31, 2019 Off

Stallergenes Greer Will Be at 2019 EAACI Congress and Present the Results of Its Phase III House Dust Mites Tablet Trial

By BusinessWire

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/EAACI2019?src=hash" target="_blank"gt;#EAACI2019lt;/agt;–Stallergenes Greer today announced that house dust mite (HDM) induced allergic rhinitis, its treatment with sublingual tablets…

Beam Therapeutics, Bio Palette in license agreements for base editing technologies
May 31, 2019 Off

Beam Therapeutics, Bio Palette in license agreements for base editing technologies

By BusinessWire

Beam Therapeutics and Bio Palette today announced an exclusive
cross-license agreement around each companies’ base editing intellectual
property.

May 31, 2019 Off

Elite High School Scientists Headed to BIO 2019 to Face Off in the BioGENEius Challenge

By BusinessWire

WASHINGTON–(BUSINESS WIRE)–Today, the Biotechnology Institute announced the 15 student winners who will advance to the final stages of the 2019…

Veeva will present at Investor Conferences
May 31, 2019 Off

Veeva will present at Investor Conferences

By BusinessWire

Veeva will present at Investor Conferences

Adaptive Biotechnologies appoints Kevin Conroy and Michelle Griffin to board of directors
May 31, 2019 Off

Adaptive Biotechnologies appoints Kevin Conroy and Michelle Griffin to board of directors

By BusinessWire

Adaptive Biotechnologies today announced Kevin Conroy, chairman and CEO
of Exact Sciences Corporation, and Michelle Griffin, director at Acer
Therapeutics, Inc. and HTG Molecular Diagnostics, Inc., have been
elected to the board of directors. Board member Arnold J. Levine, PhD,
has transitioned to Adaptive’s scientific advisory board.

Schrödinger to Present at the Jefferies 2019 Global Healthcare Conference
May 30, 2019 Off

Schrödinger to Present at the Jefferies 2019 Global Healthcare Conference

By BusinessWire

Schrödinger
today announced that Ramy Farid, Ph.D., chief executive officer, will
present at the Jefferies 2019 Global Healthcare Conference on Thursday,
June 6, 2019 at 11:00 a.m. ET in New York, NY.

May 30, 2019 Off

Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies

By BusinessWire

Lantheus expands into immuno-oncology and pharmaceutical services business through the license of NanoMab’s NM-01, an anti-PD-L1 imaging biomarker, designed to…

May 30, 2019 Off

IQVIA Real World Capabilities and Expertise Support Path to Label Expansion

By BusinessWire

Previously announced FDA approval of IBRANCE® (palbociclib) for the treatment of men with metastatic breast cancer based in part on…

Posts pagination

Previous 1 … 3,148 3,149 3,150 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine